Researchers identified ANKIB1 and K11-ubiquitin as crucial regulators of innate immune signaling and interferon production. This discovery offers therapeutic potential for diverse diseases, including cancer, neurodegenerative conditions, and inflammatory disorders.
A federal rural health improvement program faces significant state-level pushback from Republicans and medical facilities who feel disregarded over flawed definitions and fund distribution, risking states losing allocated funds if approved plans are altered, despite Congressional intent.
A new blood test measuring p-tau217 protein can roughly predict Alzheimer's symptom onset, rising consistently before memory loss. Promising for early treatment, current models have limitations regarding range and participant diversity. Future research aims to improve accuracy.
Virginia Tech research reveals how the AMPK enzyme regulates muscle energy, mitochondrial activity, and exercise performance. Its impaired function may link to diabetes, offering a new treatment target through drug therapies.
Stanford researchers developed a universal nasal spray that supercharges lung immunity for months, providing broad-spectrum protection against viruses, bacteria, and allergens in successful mouse studies.
UCR scientists developed an innovative oxygen-supplying gel to treat chronic wounds, especially diabetic ulcers. By delivering continuous oxygen to deep tissues, it combats hypoxia, reduces inflammation, and significantly lowers amputation risk, promoting faster healing.
Ancient DNA from a 12,000-year-old Italian burial revealed an inherited bone growth condition (acromesomelic dysplasia) in a mother and child, proving rare genetic diseases existed in prehistory and highlighting paleogenomics' power.
Eli Lilly's Retatrutide, a new GLP-1 drug, achieved an unprecedented 28.7% average body weight loss in trials, outperforming Zepbound. It also significantly reduced knee pain. Some side effects and dropouts were noted.
CMS controversially canceled its "Making Care Primary" program, meant to improve care and reduce costs. While CMS cites $750M savings, a CBO report questioned its fiscal impact, sparking frustration among providers concerned about rural healthcare access.
Time-restricted feeding (TRF) significantly reduces Crohn's disease activity by 40% and pain by 50% in 12 weeks, improving inflammation & gut bacteria. It also aids type 2 diabetes & weight loss, yet research shows potential risks like fertility issues or hair loss. Consult a doctor before changes.
Longevity doctor Michael Aziz discusses anti-aging peptides like Epitalon and GHK-Cu, which may extend telomeres and maintain stem cells. He also highlights Semaglutide's metabolic benefits and the risks of unregulated peptide markets.
New research reveals that clinical depression often precedes Parkinson’s and Lewy body dementia by years, serving as a biological indicator of early neurodegenerative brain changes rather than mere psychological distress.
A 20-year NIH-funded randomized trial found "speed of processing" cognitive training significantly reduced dementia risk by 25% in older adults, including Alzheimer's, making it the only intervention to show such long-term protective effects.
A study using hair samples spanning a century uncovered how environmental regulations, particularly the EPA's, dramatically reduced childhood lead exposure from sources like leaded gas. This significantly improved public health, reversing historical impacts like reduced IQ and psychological issues.
MIT researchers are using noninvasive transcranial focused ultrasound to stimulate deep brain regions, aiming to identify the neural circuits that generate conscious experience and solve the 'hard problem' of the mind.
Explore cutting-edge hair loss treatments from Korea and the US, including exosome therapy, stem cell research, and personalized science-backed solutions like light therapy and supplements.
Cancer cells package immunosuppressive PD-L1 into sEVs via UBL3, hindering immunotherapy. Researchers found widely used statins can block this process, offering a new strategy to enhance immune checkpoint therapies by reducing circulating immunosuppressive PD-L1.
